Background Adherence to evidence-based standard treatment guidelines (STGs) enable
healthcare providers to deliver consistently appropriate diagnosis and treatment. Irrational …

Objectives The slow progress of pharmacovigilance (PV) in low-income and middle-income
countries (LMIC) raises questions about core challenges on the growth of PV, and the …

Background: Both constrained access to essential medicines and combatting marketing of
substandard and falsified (SF) medicines are unmet health sector goals in Africa. Objective …

Background Preventable adverse drug reactions (ADR) and adverse events following
immunization (AEFI) are more prevalent in patients of low-and middle-income nations …

Introduction Pharmacovigilance (PV) in sub-Saharan Africa relies on passive surveillance
but underreporting of adverse events (AEs) by health care professionals (HCPs) is a major …

Background: Knowledge and skills in pharmacovigilance (PV) are required to mitigate
adverse events associated with medicine use which are among the leading causes of …

Purpose Understanding the integration of pharmacovigilance activities in the healthcare
system and identifying existing hindering factors systematically through the eyes of …

ABSTRACT Most sub-Sahara African countries faced with prolonged resource deficiencies
suffers specific constraints in establishing a functional and operationally-free …

Safety evaluation of medicines and vaccines is criti-cal to ensure patient safety and maintain
confidence in treatment and disease prevention strategies. Leveraging data pathways for …